Cost and cost effectiveness are differentBMJ 1995; 310 doi: https://doi.org/10.1136/bmj.310.6986.1070 (Published 22 April 1995) Cite this as: BMJ 1995;310:1070
- Dennis Tracey
- Medical prescribing adviser Highlands Health Board, Inverness IV2 3HG
EDITOR,—Jeannette Naish and colleagues seem surprised at the relatively low levels of generic prescribing of drugs in asthma, especially steroids.1 They should not be. Recent correspondence in the BMJ testifies to the controversy fuelled by commercial …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial